Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6.
Machado FS, Esper L, Dias A, Madan R, Gu Y, Hildeman D, Serhan CN, Karp CL, Aliberti J.
J Exp Med. 2008 May 12;205(5):1077-86. Epub 2008 Apr 14.
PMID: 18411340
doi:10.1084/jem.20072416
Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.
Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN.
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15178-83. Epub 2004 Oct 7.
PMID: 15471991
doi: 10.1073/pnas.0405445101
Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent.
Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN, Aliberti J.
Nat Med. 2006 Mar;12(3):330-4. Epub 2006 Jan 15.
PMID: 16415877
doi:10.1038/nm1355\n
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Serhan CN, Gotlinger K, Hong S, Arita M.
Prostaglandins Other Lipid Mediat. 2004 Apr;73(3-4):155-72. Review.
PMID: 15290791